✦ LIBER ✦

2227 SERUM ISOFORM [−2]PROPSA DERIVATES (%P2PSA AND PHI) SIGNIFICANTLY IMPROVES THE PREDICTION OF PROSTATE CANCER AT INITIAL BIOPSY IN A TPSA RANGE 2-10 NG/ML. A MULTICENTRIC EUROPEAN STUDY

✍ Scribed by Haese, Alexander; Lazzeri, Massimo; de la Taille, Alexandre; Palou, Joan; McNicholas, Thomas; Scattoni, Vincenzo; Lughezzani, Giovanni; Larcher, Alessandro; Lista, Giuliana; Cestari, Andrea; Renter, Anke; Bosset, Pierre Olivier; Le Corvoisier, Philippe; Fowler, Linda; Roux, Jacques William T; Breda, Alberto; de la Torre, Pablo; Bini, Vittorio; Buffi, Nicolomaria; Guazzoni, Giorgio

Book ID: 122394535
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 53 KB
Volume: 189
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.02.2136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum Isoform [−2]proPSA Derivatives Sig

Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10ng/ml: A Multicentric European Study

✍ Andriole, G.L. 📂 Article 📅 2013 🏛 Elsevier Science ⚖ 51 KB

Prostate-Specific Antigen (PSA) Isoform

Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting

✍ Giorgio Guazzoni; Luciano Nava; Massimo Lazzeri; Vincenzo Scattoni; Giovanni Lug 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 473 KB

1926 SERUM ISOFORM [-2]PROPSA (P2PSA) AN

1926 SERUM ISOFORM [-2]PROPSA (P2PSA) AND ITS DERIVATIVES, NAMELY %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN MEN YOUNGER THAN 60 YEARS OF AGE FOR PREDICTION OF PROSTATE CANCER. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY (PROMETHEUS PROJECT)

✍ McNicholas, Thomas; Lazzeri, Massimo; Haese, Alexander; de la Taille, Alexandre; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 53 KB

Clinical performance of serum prostate-s

Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS

✍ Lazzeri, Massimo; Haese, Alexander; Abrate, Alberto; de la Taille, Alexandre; Re 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

2225 CLINICAL PERFORMANCE OF SERUM ISOFO

2225 CLINICAL PERFORMANCE OF SERUM ISOFORM [−2]PROPSA (P2PSA) AND ITS DERIVATIVES, NAMELY %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN MEN WITH FAMILY HISTORY OF PROSTATE CANCER. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY (PROMETHEUS PROJECT)

✍ Lazzeri, Massimo; Haese, Alexander; de la Taille, Alexandre; McNicholas, Thomas; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 107 KB

848 Clinical performance of serum isofor

848 Clinical performance of serum isoform [−2]proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men with family history of prostate cancer. Results from a multicentric European study (PROMEtheuS project)

✍ Lazzeri, M.; Lughezzani, G.; Lista, G.; Larcher, A.; Cestari, A.; Buffi, N.; Hae 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 98 KB